Regeneron Pharmaceuticals (REGN) stock

Last close 916.06 USD (Nov 10, 2026), on the day −0.4 %.

• Sector: Healthcare, Biotechnology.
• Market cap: 95.2B USD.
• P/E: 20.0. Forward P/E: 13.0.
• Dividend yield: 0.41 %.
• Over 52 weeks: low 600.66 USD, high 973.36 USD, price change +39.9 %.
• Analysts' average 12-month target from Yahoo Finance: 978 USD (27 analysts). Not our estimate.

Earnings

• Jan 28, 2027: EPS not yet, estimate 25.39
• Oct 30, 2026: EPS 20.07, estimate 16.25
• Jul 30, 2026: EPS 14.29, estimate 10.21
• Apr 29, 2026: EPS 9.47, estimate 8.90
• Jan 30, 2026: EPS 11.44, estimate 10.75
• Oct 28, 2025: EPS 11.83, estimate 9.64

Which large investors hold it

• Dodge & Cox – 1.6 % of the portfolio
• Ray Dalio – 0.1 % of the portfolio

In baskets

• Biotech

Similar companies: ARGX · BMRN · BNTX · EXEL · INCY · MRNA · VRTX